Karuna Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Karuna Therapeutics's balance sheet done over the years? Its assets were worth $1,336,209,000 last year, which is more than in the previous period. 6% of Karuna Therapeuticsโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $81,974,000, which means an increase by 121% compared compared to last year.

Debt to Assets

Karuna Therapeutics, Inc. (NASDAQ:KRTX): Debt to assets
2017 2129000 15.49M 727.9%
2018 92479000 909K 0.98%
2019 393024000 3.10M 0.79%
2020 347625000 8.69M 2.5%
2021 527671000 25.64M 4.86%
2022 1163334000 37.09M 3.19%
2023 1336209000 81.97M 6.13%

KRTX Balance Sheet (2017 โ€“ 2023)

2023 2022 2021 2020 2019 2018 2017
Assets
Current assets:
Cash and cash equivalents
185.82M248.32M206.95M53.04M208.92M85.52M1.94M
Short term investments
1.07B875.71M287.03M269.28M180.46M4.98M0
Net receivables
4.9M57K1.75M0000
Inventory
32.83M28.32M20.88M0000
Other current assets
14.76M2.34M708K1.08M485K23K8K
Total current assets
1.31B1.15B517.33M344.59M392.70M92.21M2.11M
Non-current assets:
Property, Plant and Equipment
20.51M7.87M9.54M2.86M195K138K12K
Goodwill
0000000
Intangible assets
0000000
Long term investments
0261K261K157K123K00
Other non-current assets
382K690K792K157K0123K0
Total non-current assets
20.89M8.56M10.33M3.02M318K261K12K
Total assets
1.33B1.16B527.67M347.62M393.02M92.47M2.12M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
41.60M00000433K
Short term debt
2.84M2.28M2.17M844K58K07.67M
Total current liabilities
68.12M33.94M20.21M6.85M2.95M807K11.51M
Non-current liabilities:
Long term debt
13.84M3.04M5.32M1.84M150K102K3.98M
Deferred tax
0000000
Other non-current liabilities
0104K104K-655K001K
Total non-current liabilities
13.84M3.15M5.43M1.84M150K102K3.98M
Total liabilities
81.97M37.09M25.64M8.69M3.10M909K15.49M
Data sourceData sourceData sourceData sourceData source